iX Biopharma Ltd. announced the allotment and issuance of 80,885 new ordinary shares on Mar, 25 2026, following the exercise of warrants at 0.06 Singapore dollars per share.

The exercise lifts the company’s total issued share capital from 1,038,243,644 to 1,038,324,529 shares. The new shares are expected to begin trading on the Singapore Exchange on or around Mar, 27 2026.

To date, 7,565,084 warrants—13.15% of the total originally issued—have been exercised. A remaining 49,944,395 warrants, each with an exercise price of 0.06 Singapore dollars, will expire on Jul, 18 2026.